Stretch induces modifications in myocardial electrical and mechanical activity. Besides the effects of substances that block the stretch-activated channels, other substances could modulate the effects of stretch through different mechanisms that affect Ca 2ϩ handling by myocytes. Thirty-six Langendorff-perfused rabbit hearts were used to analyze the effects of the Na ϩ /Ca 2ϩ exchanger blocker KB-R7943, propranolol, and the adenosine A 2 receptor antagonist SCH-58261 on the acceleration of ventricular fibrillation (VF) produced by acute myocardial stretching. VF recordings were obtained with two epicardial multiple electrodes before, during, and after local stretching in four experimental series: control (n ϭ 9), KB-R7943 (1 M, n ϭ 9), propranolol (1 M, n ϭ 9), and SCH-58261 (1 M, n ϭ 9). Both the Na ϩ /Ca 2ϩ exchanger blocker KB-R7943 and propranolol induced a significant reduction (P Ͻ 0.001 and P Ͻ 0.05, respectively) in the dominant frequency increments produced by stretching with respect to the control and SCH-58261 series (control ϭ 49.9%, SCH-58261 ϭ 52.1%, KB-R7943 ϭ 9.5%, and propranolol ϭ 12.5%). The median of the activation intervals, the functional refractory period, and the wavelength of the activation process during VF decreased significantly under stretch in the control and SCH-58261 series, whereas no significant variations were observed in the propranolol and KB-R7943 series, with the exception of a slight but significant decrease in the median of the fibrillation intervals in the KB-R7943 series. KB-R7943 and propranolol induced a significant reduction in the activation maps complexity increment produced by stretch with respect to the control and SCH-58261 series. In conclusion, the electrophysiological effects responsible for stretch-induced VF acceleration in the rabbit heart are reduced by the Na ϩ /Ca 2ϩ exchanger blocker KB-R7943 and by propranolol but not by the adenosine A2 receptor antagonist SCH-58261. cardiac electrophysiology; mechanical stretch; Fourier analysis STRETCH induces the modulation of electrical and mechanical activity in myocytes. The modulation of electrical activity, also referred to as mechanoelectrical feedback (14, 35) , includes the depolarization of the resting potential (2, 17, 21, 27, 28, 31, 70) , alterations of the shape and duration of action potentials (3, 11, 21, 27, 28, 31, 47, 57, 70) , changes in refractoriness (4, 7, 9, 11, 27, 36, 47, 48) , and the induction of afterdepolarizations (16, 18, 34) . These electrophysiological changes have been related to the generation of different types of cardiac arrhythmias (7, 9, 13-15, 24, 26, 35, 40, 47 (3, 46, 66, 69) . The electrical and mechanical effects of stretch are not independent, and changes in the concentrations of intracellular Ca 2ϩ can influence electrical activity via the modulation of Ca 2ϩ -dependent currents (3, 25). A Ca 2ϩ -dependent inactivation of stretch-activated channel activity has been described (68), and activation of the delayed rectifier K ϩ current and of the Na ϩ /Ca 2ϩ exchanger is also regulated by intracellular Ca 2ϩ concentration (3, 25, 59) . Thus, besides the effects of substances that block the stretch-activated channels, other substances can modulate the electrophysiological effects of stretch through different mechanisms that affect Ca 2ϩ handling by myocytes.
been related to the generation of different types of cardiac arrhythmias (7, 9, 13-15, 24, 26, 35, 40, 47) . The mechanical effects of stretch consist of an immediate and slow increase in force (45, 64) , involving changes in myofilament Ca 2ϩ sensitivity, in the concentrations of intracellular Ca 2ϩ , and in the magnitude of Ca 2ϩ transients (1, 3, 29, 33, 58, 69) . These changes have been related to several mechanisms, including the actions of 1) endogenous angiotensin II (1, 46) ; 2) the Na ϩ /H ϩ exchanger (1, 3, 46, 66) ; 3) the Na ϩ /Ca 2ϩ exchanger (3, 46, 66, 69) ; and 4) signaling pathways with the involvement of the second messenger cAMP (3, 10) . Na ϩ influx via the stretch-activated channels that have nonselective permeability to various cations (30, 51) , or by the activation of angiotensin II and endothelin 1 receptors that stimulate the Na ϩ /H ϩ exchanger (1, 46) , or through mechanically mediated enhancement of Na ϩ /H ϩ exchanger activity (66) activates the reverse mode operation of the Na ϩ /Ca 2ϩ exchanger, increasing Ca 2ϩ influx and Ca 2ϩ transients (3, 46, 66, 69) . The electrical and mechanical effects of stretch are not independent, and changes in the concentrations of intracellular Ca 2ϩ can influence electrical activity via the modulation of Ca 2ϩ -dependent currents (3, 25) . A Ca 2ϩ -dependent inactivation of stretch-activated channel activity has been described (68) , and activation of the delayed rectifier K ϩ current and of the Na ϩ /Ca 2ϩ exchanger is also regulated by intracellular Ca 2ϩ concentration (3, 25, 59) . Thus, besides the effects of substances that block the stretch-activated channels, other substances can modulate the electrophysiological effects of stretch through different mechanisms that affect Ca 2ϩ handling by myocytes.
The present study analyzed and compared the acceleration of ventricular fibrillation (VF) activation frequency produced by acute stretch (8) under the influence of three substances: the Na ϩ /Ca 2ϩ exchanger blocker KB-R7943 (22, 23, 38, 67) , the ␤-blocker propranolol, and the adenosine A 2 receptor antagonist SCH-58261 (71) . In relation to the first of these drugs, the inactivation of the Na ϩ /Ca 2ϩ exchanger results in a decrease in the slow force response to stretch and in the magnitude of Ca 2ϩ transients (69) , although there is little information about its effects upon the electrophysiological modifications induced by stretch. Regarding the second substance, it has been shown that the load-induced changes in ventricular excitability and action potential duration are abolished by ␤-adrenergic block or by myocardial catecholamine depletion, and it has been proposed that the electrophysiological effects of stretch are produced by the activation of ␤-adrenergic receptors (37) . Finally, in regard to the third substance, the adenosine A 2 receptor has been shown to modulate Ca 2ϩ release from the sarcoplasmic retic-ulum through cAMP-dependent modulation of the ryanodine receptor (20) . Adenosine A 2 receptor stimulation produces an increase in adenylyl cyclase activity and cAMP (12, 50, 53, 54) , with a positive inotropic response similar to that seen with an increase in extracellular Ca 2ϩ concentrations (49, 52 ), although it is not known whether adenosine A 2 receptor block would modulate the electrophysiological effects of stretch. To clarify the modifications of the electrophysiological effects of stretching under the influence of these three substances, we used an isolated Langendorff-perfused rabbit heart model in which analysis of the dominant frequency (DF) and the activation patterns of VF allowed us to illustrate the electrophysiological modifications produced by acute stretch applied on the free wall of the left ventricle (8, 63) .
METHODS

Experimental Preparation
The procedures used in this study were in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals (NIH Pub. No. 85-23; Revised 1985) and with approval from the Institutional Animal Care and Use Committee. Thirty-six isolated and perfused rabbit hearts were used. The mean weight of the animals was 2.6 Ϯ 0.2 kg. After animals had been anesthetized with ketamine (25 mg/kg im) and heparinized, hearts were removed and immersed in cold (4°C) Tyrode solution. After isolation, the aorta was connected to a Langendorff system for perfusion of Tyrode solution at a pressure of 60 mmHg and a temperature of 37 Ϯ 0.5°C. The millimolar composition of the perfusion fluid was as follows: 130 NaCl, 24.2 NaHCO 3, 4.7 KCl, 2.2 CaCl2, 1.2 NaH2PO4, 0.6 MgCl2, and 12 glucose. Oxygenation was carried out with a mixture of 95% O2 and 5% CO2.
An L-shaped device was introduced through the left atrium into the left ventricular cavity to induce local stretching of the left ventricular free wall (8, 63) . The device consisted of a hollow tube measuring 3.5 mm in diameter, through which a stem 1.5 mm in diameter could be advanced. The distal end of the stem protruded from the L-shaped device and consisted of a circular platform measuring 7.5 mm in diameter, with which controlled stretching of a circumscribed zone of ventricle wall could be induced (Fig. 1) . To ensure that stretch was produced by the circular platform, and not by inappropriate displacements of the device, the latter was proximally and distally affixed to external supports. The upper part of the device was affixed with forceps located above the left atrium, while at the lower portion use was made of a suture thread knotted to the angle of the L-shaped tube and exteriorized through the ventricular apex to affix it to another external support. Left ventricular unipolar electrograms were recorded using two multiple electrodes composed of 121 and 115 unipolar stainless steel electrodes (diameter: 0.125 mm and interelectrode distance: 1 mm), respectively, positioned at the epicardial surface of the free wall of the left ventricle. One electrode was positioned in the stretched zone (SZ) located in the midportion of the anterior wall, whereas the other electrode was positioned in the nonstretched zone (NSZ) in the midportion of the posterior wall. The indifferent electrode was a 4 ϫ 6-mm silver plaque located over the cannulated aorta. Ventricular pacing was performed using bipolar electrodes (diameter: 0.125 mm and interelectrode distance: 1 mm) located in the upper or central zone of the multiple electrode. Pacing was carried out using a Grass S88 stimulator (Grass Instruments, Quincy, MA) equipped with a stimulus isolation unit (SIU5). Stimuli were rectangular pulses of 2-ms duration and an intensity twice the diastolic threshold. Recordings were obtained with a cardiac electrical activity mapping system (MAPTECH, Waalre, The Netherlands). Electrograms were amplified with a gain of 100 -300, broadband (1-400 Hz) filtered, and multiplexed. The sampling rate in each channel was 1 kHz.
Experimental Series
Four experimental series were studied: 1) control (n ϭ 9), 2) Na ϩ /Ca 2ϩ exchanger blocker KB-R7943 (n ϭ 9), 3) propranolol (n ϭ 9), and 4) adenosine A 2 receptor antagonist SCH-58261 (n ϭ 9). The experimental protocol in each series was as follows. Thirty minutes after the electrodes had been positioned, VF was induced by pacing at increasing frequencies from 4 to 20 Hz, and coronary perfusion was maintained during the arrhythmia. Five minutes after the induction of VF, perfusion of the drug (KB-R7943 at a concentration of 1 M or SCH58261 at a concentration of 1 M) was initiated. In the control series, the substance used to dissolve KB-R7943 and SCH-58261 (DMSO) was also added to the perfusion fluid 5 min after the induction of VF at the same concentration. In the propranolol series, the drug (at a concentration of 1 M) was added to the perfusion fluid from the beginning of the experiments to ensure its effects during the stretching stage of the experiments. Ten minutes after the induction of VF, stretching was applied and maintained for 10 min by displacing the stem of the L-shaped intraventricular device 6 mm, thus giving rise in the SZ to 12% longitudinal increments along the vertical and horizontal axes (8) . After this period, local stretching was discontinued, and VF recording was continued for another 5 min. The chosen concentrations of KB-R7943, SCH-58261, and propranolol were in the range of the reported concentrations used to analyze their effects (22, 23, 38, 67, 71) .
Data Analysis
VF spectral analysis. Welch's method (42) was used to obtain the power spectrum of the signals recorded with all the unipolar electrodes located in both SZ and NSZ (Fig. 1 ). Spectral analysis during VF was performed each minute before stretch induction, during stretching, and after stretch suppression. Data blocks of 4,096 points (sampling rate: 1 kHz) were analyzed, and the averages of the DF for the electrodes of SZ or NSZ were determined. DF is the frequency of the spectrogram showing the highest power spectral density (PSD), i.e., power per Hertz. PSD is calculated from the square of the signal amplitude (expressed in arbitrary units). Data processing was performed with Matlab software on a Hewlett-Packard 712/80 platform (Hewlett-Packard, Palo Alto, CA).
VF time-domain analysis. Activation times in each electrode were determined by identifying the moment of maximum negative slope of the ventricular electrograms. The minimal threshold for dV/dt to be judged as a local deflection was a percentage (20%) of the maximal negative slope in each channel. If electrograms exhibited two or more deflections, then the steepest slope of the activation complex was assigned as the local activation time. The fibrillation interval (VV) histograms and the median and 5th percentile of the consecutive VV intervals ( Fig. 1) were determined for the recordings obtained with all 121 unipolar electrodes of the multiple electrode placed in the SZ and the 115 unipolar electrodes of the multiple electrode placed in the NSZ during time windows of 2 s analyzed immediately before stretch application and at the third minute of the stretching and poststretching periods. These time windows were chosen based on the previous faster analysis of the time course of the DF changes during the three experimental phases. This analysis allowed us identify the moments of maximum effect of the stretch and the minimum delay until the effects of stretch disappear after suppressing it.
VF epicardial activation maps. Activation maps during VF were constructed every 100 ms in the 2-s time windows analyzed immediately before stretch and at the third minute of the stretching and poststretching periods. Isochrones were drawn, and, in each map, the wavefronts, conduction block lines, reentrant activations, and breakthrough patterns were analyzed as in previous studies (6, 8) (Figs. 2 and 3 ). Each map was classified into three categories based in its complexity: type I, single broad wavefronts without conduction block lines or areas of slow conduction; type II, two wavefronts or one wavefront with areas of conduction block or slow conduction; and type III, Ն3 wavefronts associated with areas of slow conduction and conduction block.
Electrophysiological parameters. The conduction velocity, refractoriness, and wavelength of the activation process were determined during VF (6, 8) . Conduction velocity was calculated dividing the distance between two electrodes positioned five interelectrode spaces apart in a direction perpendicular to the isochrones by the difference between their activation times (average of 5 determinations). Only those maps in which both the input and output of wavefronts were identified at the edges of the activation maps were used. The functional refractory period during VF was regarded as the average of the five smallest intervals between two successive activations by two different wavefronts recorded in an electrode. The wavelength during Fig. 2 . Bidimensional (left) and three-dimensional (right) representations of the three types of activation maps classified according their complexity. The type I map shows a single broad wavefront that cross the epicardial surface encompassed by the multiple electrode. The type II map shows two different wavefront; the first wavefront enters from the left lower corner and blocks after a short distance, and, shortly after, a new wavefront enters from the lower right edge. The type III map shows three different wavefronts with areas of conduction block. In this map, the two earliest wavefronts collide, and, shortly after, a new wavefront enters from the lower right corner. Act. Time, activation time (in ms).
VF was the product of functional refractory period and conduction velocity.
Statistical Calculations
Data are presented as means Ϯ SD. The general lineal model was used to analyze the differences in each series (differences within subjects and repetitive measurements) and to compare the series (differences between subjects). Values of P Ͻ 0.05 were considered statistically significant. Differences between qualitative variables were analyzed by the 2 -test.
RESULTS
Control Series
In the SZ, the DF increased during stretching (Figs. 4 and 5 ). The differences with respect to the determinations before stretching (15.1 Ϯ 2.2 Hz) were statistically significant from minutes 1 to 10, and the maximum values were observed at minute 2 (22.5 Ϯ 2.8 Hz, P Ͻ 0.0001) and minute 3 (22.1 Ϯ 3.4 Hz, P Ͻ 0.0001), followed by a gradual reduction of the increments. On the suppression of stretch, the DF returned to baseline values. The median and 5th percentile of the VV intervals, functional refractory period, and wavelength during VF decreased significantly during the stretching phase and returned to previous values on the suppression of stretch (Figs. 6 and 7 and Table 1 ). No significant variations were observed in conduction velocity. The activation map complexity increased during stretch (Fig. 8) . No significant differences were observed in the number of maps with breakthrough patterns [prestretch: 26%, stretch: 33%, and poststretch: 18%, not significant (NS)], in the number of maps with reentry patterns (prestretch: 4%, stretch: 4%, and poststretch: 10%, NS), and in the number of consecutive rotations during reentrant activations (prestretch: 1.1 Ϯ 0.1, stretch: 1.1 Ϯ 0.1, and poststretch: 1.1 Ϯ 0.2, NS). In the NSZ, the variations in DF, median and 5th percentile of the VV intervals, refractory period, conduction velocity, wavelength, and activation map characteristics were not statistically significant (Figs. 5-7 and Table 1 ).
KB-R7943 Series
Five minutes after the KB-R7943 perfusion was begun, the DF did not vary significantly (SZ: 14.5 Ϯ 0.8 vs. 14.8 Ϯ 0.9 Hz, NS; and NSZ: 13.9 Ϯ 0.8 vs. 14.4 Ϯ 0.9 Hz, NS), and the values were similar to those found in the control series (SZ: 14.5 Ϯ 0.8 vs. 15.1 Ϯ 2.2 Hz, NS; and NSZ: 13.9 Ϯ 0.8 vs. 14.1 Ϯ 0.9 Hz, NS). In the SZ, the variations in DF with respect to the determinations made before stretching were not statistically significant (Figs. 4 and 5) : DF was 15.8 Ϯ 1.9 Hz (NS) at minute 2 of stretching and 15.4 Ϯ 1.7 Hz at minute 3 (NS). After stretch suppression, DF remained similar to the baseline values. The median of the VV intervals decreased slightly but significantly during stretching, and the variations in the 5th percentile of the VV intervals, functional refractory period, conduction velocity, wavelength, and activation map complexity did not reach statistical significance (Figs. 6 -8 and Table 1 ). After stretch suppression, values were similar to those recorded before stretching. No significant differences were observed in the number of maps with breakthrough patterns (prestretch: 18%, stretch: 25%, and poststretch: 21%, NS) and with reentry patterns (prestretch: 3%, stretch: 4%, poststretch: 9%, NS). The number of consecutive rotations during reentrant activations were similar before stretch (1.1 Ϯ 0.2), during stretch (1.2 Ϯ 0.2), and after the suppression of stretch (1.1 Ϯ 0.1). In the NSZ, DF, the median and 5th percentile of the VV intervals, refractory period, conduction velocity, and activation map characteristics remained without significant changes during the three phases of the experimental protocol (Figs. 5-7 and Table 1 ).
Propranolol Series
Before stretching, the DF was significantly lower than in the control series in both study zones (SZ: 11.8 Ϯ 0.6 vs. 15.1 Ϯ 2.2 Hz, P Ͻ 0.0001; and NSZ: 11.0 Ϯ 1.0 vs. 14.1 Ϯ 0.9 Hz, P Ͻ 0.0001). As in the KB-R7943 series, in the SZ during stretching, there were no significant variations in DF, and the values remained constant after the suppression of stretch (Figs.  4 and 5) . Thus, the DF was 12.4 Ϯ 1.0 Hz (NS) at minute 2 of the stretching period and 12.9 Ϯ 1.1 Hz (NS) at minute 3. The variations in the median and 5th percentile of the VV intervals and in the electrophysiological parameters likewise lacked statistical significance (Figs. 6 and 7 and Table 1 ). The activation map complexity increased during the stretching period (type II maps increment and type I maps decrement) returning to prestretch characteristics in the poststretch period (Fig. 8) .
The number of maps with breakthrough patterns (prestretch: 16%, stretch: 12%, and poststretch: 14%, NS) and reentry patterns (prestretch: 6%, stretch: 6%, and post-stretch: 2%, NS) remained without significant variations, and the same was seen in the number of consecutive rotations during reentrant activations (prestretch: 1.2 Ϯ 0.3, stretch: 1.0 Ϯ 0.1, and poststretch: 1.1 Ϯ 0.1, NS). In the NSZ, the variations in DF, median and 5th percentile of the VV intervals, and electrophysiological parameters likewise lacked statistical significance (Figs. 5-7 and Table 1 ). 
SCH-58261 Series
The DF 5 min after SCH-58261 was introduced did not vary significantly (SZ: 16.1 Ϯ 1.4 vs. 15.5 Ϯ 1.7 Hz, NS; and NSZ: 15.1 Ϯ 1.7 vs. 14.7 Ϯ 1.6 Hz, NS) and was similar to values recorded in the control group (SZ: 16.1 Ϯ 1.4 vs. 15.1 Ϯ 2.2 Hz, NS; and NSZ: 15.1 Ϯ 1.7 vs. 14.1 Ϯ 0.9 Hz, NS). During stretching, the DF increased significantly in the SZ (Figs. 4 and  5) . In the SZ, the differences versus before stretching were significant from minutes 1 to 10 and likewise disappeared after the suppression of stretch. The maximum DF was observed at minute 3 (24.1 Ϯ 3.5 Hz, P Ͻ 0.0001). As in the control series, the median and 5th percentile of the VV intervals, functional refractory period, and wavelength during VF decreased significantly during stretch and returned to previous values after suppression of stretch (Figs. 6 and 7 and Table 1 ). No significant variations were observed in conduction velocity. There was also an increase in the complexity of the activation maps (Fig. 8) and in the number of maps with reentry patterns (prestretch: 4%, stretch: 18%, and poststretch: 7%, P Ͻ 0.01) without significant changes in the number of consecutive rotations (prestretch: 1.1 Ϯ 0.2, stretch: 1.4 Ϯ 0.5, and poststretch: 1.1 Ϯ 0.1, NS). As in the control series, nonsignificant differences were observed in the number of maps with breakthrough patterns (prestretch: 28%, stretch: 33%, and poststretch: 20%, NS). In the NSZ, the variations in the median and 5th percentile of the VV intervals, refractory period, conduction velocity, and activation map characteristics were not statistically significant (Figs. 5-7 and Table 1 ). A trend toward VF acceleration was observed after the suppression of stretch, and the differences reached statistical significance at minute 5 after stretch suppression.
Comparison of the Effects of Stretch in the Four Experimental Series
When DF determined in the four experimental series was analyzed, in the SZ, the differences with respect to the control series were statistically significant in the KB-R7943 series (P Ͻ 0.001) and in the propranolol series (P Ͻ 0.05), whereas the differences between the control and SCH-58261 series were not significant. In the NSZ, no differences were seen between the control, KB-R7943, and SCH-58261 series, whereas the differences were significant with respect to the propranolol series (P Ͻ 0.001). Both the Na ϩ /Ca 2ϩ exchanger blocker KB-R7943 and propranolol induced a reduction in DF increments produced by stretching with respect to the control series. Thus, the maximum increment obtained in the control Fig. 4 . Spectrograms corresponding to the recordings obtained in an experiment of each series with one of the electrodes located in the SZ. During stretch, the DFr increased in the control and SCH-58261 series, whereas almost no variations were seen in the KB-R7943 and propranolol series. f(Hz), frequency (in Hz). For increased clarity, only 1-s VF recordings are shown, although the spectrograms were obtained from data blocks of 4,096 points at a sampling rate of 1 kHz. series was 49.9% versus 9.5% in the KB-R7943 series and 12.5% in the propranolol series. In the SCH-58261 series, the maximum percentage increment (52.1%) was similar to that found in the control series, although the increments remained higher than in the control series during the last minutes of stretching.
When the effects of stretch on activation map complexity were analyzed, KB-R794 and propranolol induced a reduction in activation map complexity increments produced by stretching with respect to the control (P Ͻ 0.0001) and SCH-58261 (P Ͻ 0.0001) series.
DISCUSSION
The main findings of this study are that the electrophysiological effects responsible for stretch-induced VF acceleration in the rabbit heart are lowered by the Na ϩ /Ca 2ϩ exchanger blocker KB-R7943 and the ␤-blocker propranolol but persist under the action of the adenosine A 2 receptor antagonist SCH-58261.
Effects of the Na ϩ /Ca 2ϩ Exchanger Blocker KB-R7943
Under the action of the Na ϩ /Ca 2ϩ exchanger blocker KB-R7943, the baseline VF activation frequency was found to be similar to that recorded in the control series. In the control series, we recorded VF acceleration under stretch in the modified zone, whereas no significant changes were noted in the nonmodified zone, similar to our previous findings using a similar experimental preparation (8, 63) . The VF modifications were limited to the zone subjected to myocardial stretching in which the stretch-induced shortening of refractoriness and the decrease in wavelength made it possible to sustain faster and more complex activation patterns during VF. This fact indicates that the arrival of wavefronts from zones with faster activation is limited by the local electrophysiological characteristics of the myocardial tissue (8) . Both the acceleration of VF in a given zone and the modification of the electrophysio- 6 . Mean values Ϯ SD of the median of the activation intervals during VF in the SZ and NSZ obtained before stretching, during stretching, and after stretch suppression in each experimental series. *P Ͻ 0.05, differences with respect to before stretch. Fig. 7 . Mean values Ϯ SD of the 5th percentile of the activation intervals during VF in the SZ and NSZ obtained before stretching, during stretching, and after stretch suppression in each experimental series. P5 VV, 5th percentile of the activation intervals during VF (in ms). *P Ͻ 0.05, differences with respect to before stretch. logical properties in the limiting zones seem to be necessary for more extensive VF acceleration to occur.
In the series exposed to the action of KB-R7943, we found VF acceleration in the modified zone to be of lesser magnitude than in the control series. We also observed that the significant reduction in the 5th percentile of the VV intervals, refractory period, and wavelength and the significant increment in activation map complexity obtained in the control series during stretch were significantly reduced by the Na ϩ /Ca 2ϩ exchanger blocker. The similar variations in the 5th percentile of the VV intervals and refractory period agree with the results of a previous study (5) in which the 5th percentile has been proposed as a surrogate measurement of the effective refractory period during VF. On the other hand, frequency and timedomain techniques supply analogous information in the analysis of VF activation frequency as previously seen (6, 8, 41) , although the presence of double and multiple potentials can condition DF values (8) . In this experimental series, both techniques supplied slightly different results during stretching (the variations in DF did not reach statistical significance, but the variations in the median of the VV intervals became significant). With regard to conduction velocity, no major variations were observed during stretch in the four experimental series. In previous studies (7, 9, 13), it was described how stretching applied to the rabbits atrial wall reduced the conduction velocity, whereas in other studies in which stretch was applied globally to the ventricle (48) or using the same experimental method as in the present study (8) , no major variations of this parameter were observed. In one of the cited works (7), the observed reduction was obtained by applying a higher degree of stretching than in this study. The differences found could be due to the different level of stretching applied or to differing behavior of the atrial or ventricle myocardium.
Thus, the Na ϩ /Ca 2ϩ exchanger blocker KB-R7943 lowered the electrophysiological effects responsible for stretch-induced VF acceleration. In a previous study (63) , we likewise showed that the nonspecific stretch-activated channel blocker streptomycin also lowers these effects. The mechanism of action of the Na ϩ /Ca 2ϩ exchanger blocker KB-R7943 would be different to that of the stretch-activated channel blockers. These channels exhibit nonselective permeability to monovalent and divalent cations, including Na ϩ and Ca 2ϩ (30, 51) , although other mechanisms may influence Na ϩ influx, such as Na ϩ /H ϩ exchanger activation via direct mechanical signals or mech- concentrations regulate the function of the Na ϩ /Ca 2ϩ exchanger (3, 25, 59, 69) . Such regulation could involve the participation of local mechanisms through higher Na ϩ concentrations in the submembrane space (56) . Thus, stretch modifies the equilibrium of the Na ϩ /Ca 2ϩ exchanger, and altered Ca 2ϩ concentrations can modulate the ionic currents responsible for the electrophysiological properties of myocytes and their electrical restitution curves (25) . The Na ϩ /Ca 2ϩ exchanger blocker KB-R7943 would modify the effects of stretch by reducing Ca 2ϩ influx (69) and thus the changes in electrophysiological properties linked to Ca 2ϩ -dependent currents.
Effects of Propranolol
The effects of ␤-receptor agonists and antagonists upon myocardial activation patterns during VF have been studied by several authors. Epinephrine shortens the fibrillation cycle length (19, 62) , and this effect is related to a shortening of refractoriness (60) , since myocardial refractory periods determine fibrillation cycle length (6, 43, 55, 60) . Action potential and refractoriness shortening produced by ␤-receptor agonists occurs through the cAMP-mediated activation of protein kinases that regulate transmembrane ionic currents (61) , and these effects are reversed by propranolol (60) . On the other hand, propranolol decreases the epicardial activation rate during VF in pig hearts, and this effect has been related to an increased refractory period leading to a decrease in the number of activation fronts during the arrhythmia (19) . Similar results have been reported in Langendorff-perfused rabbit hearts (44) . These authors found that propranolol prolongs the VF cycle length and converts fast VF into slow VF, reducing the activation rate in the epicardial recordings during this arrhythmia. Our results coincide with the observations of Pak et al. (44) , since during the phase before myocardial stretching in the propranolol-treated series, VF was seen to be slower than in the control series. Refractoriness and wavelength were prolonged, and the VF activation map complexity was reduced. These changes were also noted in the other two experiment phases of this series, i.e., under conditions of stretch and after the suppression of stretch. The DF increments produced by stretching were not significant. The activation map complexity increased slightly but significantly during stretching, although without reaching the levels of the control series. In other words, propranolol, in addition to slowing VF under baseline conditions, also avoids its stretch-induced acceleration and diminishes the increment in the activation map complexity produced by stretching. In a previous study (37) , it was observed that the load-induced changes in ventricular excitability and action potential duration are abolished by ␤-adrenergic block or by myocardial catecholamine depletion. For this reason, it has been suggested that the electrophysiological effects of stretch are produced by the activation of ␤-adrenergic receptors as a result of the stretch-mediated release of catecholamines from intramyocardial nerve endings (37) . The changes in delayed rectifier K ϩ current produced by the increase in cAMP or by increased intracellular Ca 2ϩ would be responsible for the shortening of ventricular refractoriness induced by stretch, with these effects in turn being countered by ␤-receptor block.
Effects of the Adenosine A 2 receptor Antagonist SCH-58261
The adenosine A 2 receptor is a G s protein-coupled receptor that exerts cAMP-dependent modulation of intracellular Ca 2ϩ handling. Its stimulation augments myocardial contractility, and this response is prevented by adenosine A 2 receptor antagonists. The inotropic response is produced by an increase in adenylyl cyclase and cAMP activity (12, 50, 53, 54) and is similar to the response induced by an increase in extracellular Ca 2ϩ concentration (39, 49, 52) . A cAMP-dependent protein kinase produces hyperphosphorylation of the ryanodine receptor and an increase in spontaneous Ca 2ϩ release from the sarcoplasmic reticulum. Among the mechanisms proposed to explain the stretch-induced increments in Ca 2ϩ transients, mention can be made of the increase in Ca 2ϩ release from the sarcoplasmic reticulum (3, 29, 65) , caused by an increased open probability of the ryanodine receptor through S-nitrosylation of the latter. However, although the changes in intracellular Ca 2ϩ have been related to the electrophysiological effects of stretch (3, 59) , in the present study, we found that SCH-58261 did not avoid the modifications in VF activation frequency and complexity of the activation patterns. Furthermore, in this series, the time-related decay in VF acceleration observed during the last minutes of the stretching period was less accentuated than in the control series. We do not know whether this behavior may be related to modification of the recently described slow force decline after the maximal force increase induced by stretch (32) . Thus, regarding the actions of the adenosine A 2 receptor antagonist SCH-58261, the results obtained in the experimental model used in this study show that it does not avoid the stretch-induced electrophysiological changes leading to VF acceleration.
Limitations
The existence of differences among species must be taken into account when interpreting the results obtained in the experimental model used. On the other hand, the methodology applied in the present study involves acute stretch application, and the effects of stretch can give rise to different manifestations in chronic preparations and in situ heart preparations, due to, among other factors, the existence of associated neurohumoral reflexes. Acute local stretching applied in the left ventricular wall could have interfered with perfusion, producing ischemia. Although local determinations of the coronary flow were not obtained, in a previous study (8) no significant modifications in global coronary flow were observed on the application of three degrees of stretch. In the present study, a medium degree of stretch was applied.
Clinical Implications
Myocardial stretch occurs in different clinical situations involving volume or pressure overload and regional contraction abnormalities (24) . The electrophysiological changes induced by myocardial stretching are involved in an increased vulnerability to different types of cardiac arrhythmias, including atrial fibrillation and VF (7, 15, 24, 40, 47) . In the present study, it has been observed that both the Na ϩ /Ca 2ϩ exchanger blocker KB-R7943 and propranolol modify the electrophysiological effects of stretch. ␤-Blockers have demonstrated clinical utility in the treatment of various rhythm disorders, and the reduction of the electrophysiological effects of stretching could help produce this protecting effect. Information is not available about the possible clinical utility of Na ϩ /Ca 2ϩ exchange blockers to counteract the electrophysiological effects of stretch, although the observed results support the development of studies to analyze the possible protecting effects of these drugs.
Conclusions
In the experimental preparation used in this study, KB-R7943 and SCH-58261 did not modify the baseline VF dominant frequency, whereas propranolol slowed the arrhythmia. On the application of acute myocardial stretch, the electrophysiological effects responsible for the induced VF acceleration in the modified zone were lowered by the Na ϩ /Ca 2ϩ exchanger blocker KB-R7943 and by propranolol but not by the adenosine A 2 receptor antagonist SCH-58261.
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